Jérôme Galon

Galon received his Ph.D. degree (Doctorat ès science) with specialty in immunology in 1996. and did postdoctoral work at the National Institute of Health (NIH), in Bethesda (USA) between 1997 and 2001. Since 2001, he has been working at the Cordeliers Research Center, where he has been the Director of the INSERM Laboratory Integrative Cancer Immunology since 2009.[1]

His work aims at a better understanding of the tumor microenvironment and the dynamics of the immune response in humans tumors. His laboratory has identified and demonstrated the importance of the immune contexture against cancer. He defined the Immunoscore as a new method for routine clinical assessment of prognosis of patients with cancer.

• NIH Excellence Research Award (1999)
• Prix Shaeverbeke from Fondation de France (2008)
• Prix Rose Lamarca from Fondation pour la recherche médicale (2008)
• William B. Coley Award of the Cancer Research Institute (2010)
• Prix Simone et Cino Del Duca from the French Academy of Sciences Académie des sciences (2011)
• Prix Gallet et Breton from the French Academy of Medicine Académie de médecine (2011)
• European Inventor Award (2019)

• Galon J*, et al. "Towards the introduction of the Immunoscore in the classification of malignant tumors." J Pathol. 2013 Oct 3. doi: 10.1002/path.4287.
• Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell HK, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J* "Spatio-temporal dynamics of intratumoral cells reveal the immune landscape in human cancer. Immunity. 2013 Oct 17;39(4):782-95.
• Galon J*, Angell HK, Bedognetti D, and Marincola F. "The continuum of cancer immunosurveillance: prognostic, predictive and mechanistic signatures." Immunity. 2013 July 39(1), 11-26

• Laboratory of Integrative Cancer Immunology homepage
• Official CV at Laboratory of Integrative Cancer Immunology